News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
385,257 Results
Type
Article (14920)
Company Profile (85)
Press Release (369695)
Multimedia
Podcasts (54)
Webinars (10)
Section
Business (128319)
Career Advice (469)
Deals (18714)
Drug Delivery (50)
Drug Development (31339)
Employer Resources (52)
FDA (8877)
Job Trends (7732)
News (173455)
Policy (12425)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Standard (3)
2027 Pharm Country Standard (4)
Academia (1357)
Accelerated approval (16)
ADA (15)
Adcomms (1)
Allergies (109)
Alliances (34949)
ALS (61)
Alzheimer's disease (730)
Antibody-drug conjugate (ADC) (301)
Approvals (9268)
Artificial intelligence (655)
ASCO (97)
Autoimmune disease (168)
Automation (56)
Bankruptcy (133)
Best Places to Work (6518)
BIO (34)
Biologics (1)
BIOSECURE Act (7)
Biosimilars (53)
BioSpace Insights (94)
Biotechnology (68)
Bladder cancer (78)
Brain cancer (42)
Breast cancer (343)
Cancer (3032)
Cardiovascular disease (213)
Career advice (422)
Career pathing (13)
CAR-T (262)
CDC (12)
Celiac Disease (1)
Cell therapy (655)
Cervical cancer (35)
Clinical research (26797)
Collaboration (1732)
Commercialization (2)
Company closure (1)
Compensation (330)
Complete response letters (18)
COVID-19 (1261)
CRISPR (111)
C-suite (782)
Cystic fibrosis (65)
Data (3891)
Decentralized trials (2)
Denatured (27)
Depression (60)
Dermatology (42)
Diabetes (310)
Diagnostics (5536)
Digital health (58)
Diversity (7)
Diversity, equity & inclusion (9)
Drug discovery (267)
Drug pricing (19)
Drug shortages (6)
Duchenne muscular dystrophy (123)
Earnings (42187)
Editorial (10)
Employer branding (8)
Employer resources (47)
Events (55054)
Executive appointments (687)
FDA (11107)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (11)
Frontotemporal dementia (15)
Funding (1200)
Gene editing (222)
Generative AI (52)
Gene therapy (453)
GLP-1 (345)
Government (1307)
Grass and pollen (3)
Guidances (238)
Healthcare (10062)
Hematology (67)
HIV (45)
Huntington's disease (17)
IgA nephropathy (40)
Immunology and inflammation (90)
Immuno-oncology (41)
Indications (107)
Infectious disease (1473)
Inflammatory bowel disease (92)
Inflation Reduction Act (5)
Influenza (99)
Intellectual property (221)
Interviews (51)
IPO (8079)
IRA (10)
Job creations (1438)
Job search strategy (365)
JPM (21)
Kidney cancer (6)
Labor market (27)
Layoffs (141)
Leadership (8)
Legal (2539)
Licensing (5)
Liver cancer (51)
Longevity (21)
Lung cancer (334)
Lymphoma (249)
Machine learning (51)
Management (19)
Manufacturing (837)
Marketing (2)
MASH (47)
Medical device (12114)
Medtech (12347)
Mergers & acquisitions (11461)
Metabolic disorders (558)
mRNA (184)
Multiple sclerosis (80)
NASH (3)
Neurodegenerative disease (206)
Neuropsychiatric disorders (24)
Neuroscience (1376)
NextGen: Class of 2026 (3542)
Non-profit (1553)
Now hiring (20)
Obesity (177)
Opinion (113)
Ovarian cancer (136)
Pain (153)
Pancreatic cancer (164)
Parkinson's disease (182)
Partnered (23)
Patents (438)
Patient recruitment (424)
Peanut (41)
People (34467)
Pharmaceutical (12)
Pharmacy benefit managers (7)
Phase 1 (9832)
Phase 2 (12005)
Phase 3 (7816)
Pipeline (5745)
Policy (69)
Postmarket research (502)
Preclinical (4416)
Press Release (66)
Prostate cancer (153)
Psychedelics (6)
Radiopharmaceuticals (242)
Rare diseases (459)
Real estate (3422)
Recruiting (23)
Regulatory (11226)
Reports (25)
Research institute (1335)
Resumes & cover letters (69)
Rett syndrome (35)
RNA editing (16)
RSV (52)
Schizophrenia (39)
Series A (225)
Series B (145)
Service/supplier (4)
Sickle cell disease (44)
Special edition (1)
Spinal muscular atrophy (65)
Sponsored (24)
Startups (2557)
State (2)
Stomach cancer (2)
Supply chain (68)
Tariffs (12)
The Weekly (25)
Vaccines (633)
Venture capital (65)
Weight loss (69)
Women's health (79)
Worklife (4)
Date
Today (5)
Last 7 days (201)
Last 30 days (1157)
Last 365 days (14823)
2026 (9813)
2025 (15027)
2024 (18698)
2023 (22095)
2022 (30803)
2021 (32525)
2020 (30541)
2019 (25840)
2018 (19460)
2017 (18871)
2016 (17761)
2015 (20564)
2014 (15182)
2013 (12745)
2012 (13781)
2011 (14067)
2010 (12829)
Location
Africa (336)
Alabama (82)
Alaska (6)
Arizona (247)
Arkansas (12)
Asia (25506)
Australia (4399)
California (7051)
Canada (2109)
China (837)
Colorado (377)
Connecticut (335)
Delaware (151)
Europe (52418)
Florida (1230)
Georgia (282)
Hawaii (2)
Idaho (34)
Illinois (688)
India (58)
Indiana (327)
Iowa (12)
Japan (401)
Kansas (114)
Kentucky (27)
Louisiana (35)
Maine (25)
Maryland (936)
Massachusetts (4637)
Michigan (345)
Minnesota (521)
Mississippi (5)
Missouri (127)
Montana (29)
Nebraska (15)
Nevada (65)
New Hampshire (89)
New Jersey (2001)
New Mexico (24)
New York (1841)
North Carolina (977)
North Dakota (10)
Northern California (3158)
Ohio (229)
Oklahoma (22)
Oregon (25)
Pennsylvania (1303)
Puerto Rico (25)
Rhode Island (42)
South America (525)
South Carolina (84)
South Dakota (1)
Southern California (3117)
Tennessee (137)
Texas (1205)
United States (25865)
Utah (264)
Vermont (2)
Virginia (126)
Washington D.C. (18)
Washington State (619)
West Virginia (3)
Wisconsin (125)
Wyoming (2)
385,257 Results for "seegene technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)
July 27, 2026
·
5 min read
Press Releases
Seegene Launches Industry’s First Global Million Clinical Study to Shape New Disease-Specific Testing Standards
July 8, 2026
·
3 min read
Press Releases
Seegene USA Receives FDA Emergency Use Authorization for Multiplex PCR Assay, Advancing Differential Diagnosis of HSV-1&2, VZV, and Monkeypox Virus for Ulcerative Skin Lesions
July 22, 2026
·
5 min read
Press Releases
Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR Workflows
April 20, 2026
·
5 min read
Press Releases
Seegene Establishes French Subsidiary to Expand European Footprint
December 8, 2025
·
2 min read
Press Releases
Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics
July 2, 2025
·
4 min read
Biotech Beach
Seegene Technologies, Inc. Announces Name Change to Seegene USA, Inc.Company expands presence and support in US market
Seegene Technologies, Inc. announced it will change names and begin doing business as Seegene USA, Inc. , effective Jan. 1, 2023.
January 6, 2023
·
1 min read
Press Releases
Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Advancing the Next Stage of Diagnostics
August 6, 2025
·
5 min read
Press Releases
Seegene Unveils HPV Genotyping Solution at EUROGIN 2025
March 20, 2025
·
3 min read
Press Releases
Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative
October 9, 2024
·
4 min read
1 of 38,526
Next
